Guohui Jiang

429 total citations
17 papers, 300 citations indexed

About

Guohui Jiang is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Guohui Jiang has authored 17 papers receiving a total of 300 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 4 papers in Oncology and 3 papers in Surgery. Recurrent topics in Guohui Jiang's work include Epigenetics and DNA Methylation (2 papers), Cancer therapeutics and mechanisms (2 papers) and Ubiquitin and proteasome pathways (2 papers). Guohui Jiang is often cited by papers focused on Epigenetics and DNA Methylation (2 papers), Cancer therapeutics and mechanisms (2 papers) and Ubiquitin and proteasome pathways (2 papers). Guohui Jiang collaborates with scholars based in China. Guohui Jiang's co-authors include Lixia Ji, Zhihong Yang, Zhantao Liu, Hui Gao, Ji Zhou, Qingxia Ma, Mei Han, Xiaoyi Zhang, Ranran Liu and Jing Xie and has published in prestigious journals such as Advanced Functional Materials, Life Sciences and BioMed Research International.

In The Last Decade

Guohui Jiang

17 papers receiving 299 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guohui Jiang China 12 190 75 39 37 36 17 300
Qing Nian China 12 190 1.0× 49 0.7× 58 1.5× 47 1.3× 59 1.6× 30 351
Guize Feng China 10 157 0.8× 45 0.6× 52 1.3× 28 0.8× 31 0.9× 17 295
Eun-Kyung Kim South Korea 10 227 1.2× 49 0.7× 30 0.8× 44 1.2× 24 0.7× 11 328
Ling Cheng China 12 175 0.9× 78 1.0× 37 0.9× 50 1.4× 41 1.1× 24 328
Chuanbing Shi China 10 253 1.3× 61 0.8× 26 0.7× 65 1.8× 40 1.1× 22 441
Guanglu Dong China 10 177 0.9× 69 0.9× 43 1.1× 53 1.4× 30 0.8× 23 330
Yun Su China 12 176 0.9× 78 1.0× 19 0.5× 49 1.3× 33 0.9× 27 345
Mei‐Due Yang Taiwan 12 144 0.8× 102 1.4× 21 0.5× 58 1.6× 40 1.1× 32 353
Mabel Catalán Chile 14 195 1.0× 53 0.7× 28 0.7× 52 1.4× 51 1.4× 27 367
Mengli Gu China 10 153 0.8× 45 0.6× 27 0.7× 47 1.3× 57 1.6× 18 311

Countries citing papers authored by Guohui Jiang

Since Specialization
Citations

This map shows the geographic impact of Guohui Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guohui Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guohui Jiang more than expected).

Fields of papers citing papers by Guohui Jiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guohui Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guohui Jiang. The network helps show where Guohui Jiang may publish in the future.

Co-authorship network of co-authors of Guohui Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Guohui Jiang. A scholar is included among the top collaborators of Guohui Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guohui Jiang. Guohui Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Xu, Chunxue, Li Wang, Wenshan Lv, et al.. (2025). Gestational diabetes mellitus-derived miR-7-19488 targets PIK3R2 mRNA to stimulate the abnormal development and maturation of offspring-islets. Life Sciences. 363. 123369–123369. 1 indexed citations
2.
Jiang, Guohui, Qiqi Xu, Jiani Xie, et al.. (2024). Emerging Nanozymes in Neurological Disorder Therapeutics: Bridging Oxidoreductase Mimicry and Antioxidant Chemistry. Advanced Functional Materials. 34(39). 17 indexed citations
3.
Zhang, Xiaoyi, et al.. (2022). Identification of Potential Biomarkers of Type 2 Diabetes Mellitus‐Related Immune Infiltration Using Weighted Gene Coexpression Network Analysis. BioMed Research International. 2022(1). 9920744–9920744. 9 indexed citations
4.
Zhou, Jing, Li Zhao, Mingyue Chen, et al.. (2022). Intestinal Flora Composition Determines Microglia Activation and Improves Epileptic Episode Progress. Frontiers in Cellular and Infection Microbiology. 12. 835217–835217. 16 indexed citations
5.
Wang, Li, et al.. (2022). Probiotics alleviate maternal metabolic disorders and offspring-islet abnormalities in gestational diabetic mice. Journal of Functional Foods. 99. 105300–105300. 5 indexed citations
6.
Zhou, Ji, et al.. (2021). Piperine protects against pancreatic β-cell dysfunction by alleviating macrophage inflammation in obese mice. Life Sciences. 274. 119312–119312. 16 indexed citations
7.
Zhang, Xiaoyi, Ji Zhou, Zhihong Yang, et al.. (2021). To Betray or to Fight? The Dual Identity of the Mitochondria in Cancer. Future Oncology. 17(6). 723–743. 10 indexed citations
8.
Zhou, Ji, et al.. (2020). Piperine ameliorates insulin resistance via inhibiting metabolic inflammation in monosodium glutamate-treated obese mice. BMC Endocrine Disorders. 20(1). 152–152. 27 indexed citations
9.
Ji, Lixia, Mei Han, Jing Xie, et al.. (2020). Pyroptosis is involved in the inhibitory effect of FL118 on growth and metastasis in colorectal cancer. Life Sciences. 257. 118065–118065. 52 indexed citations
10.
Zhou, Ji, et al.. (2020). New insights into the links between anti-diabetes drugs and gut microbiota. Endocrine Connections. 10(1). R36–R42. 13 indexed citations
11.
Shi, Xinyan, Zhen Tan, Man He, et al.. (2019). Squalene epoxidase promotes the proliferation and metastasis of lung squamous cell carcinoma cells though extracellular signal‐regulated kinase signaling. Thoracic Cancer. 10(3). 428–436. 36 indexed citations
12.
Ji, Lixia, et al.. (2019). Key roles of Rho GTPases, YAP, and Mutant P53 in anti‐neoplastic effects of statins. Fundamental and Clinical Pharmacology. 34(1). 4–10. 11 indexed citations
13.
Ma, Qingxia, Luyao Wang, Hui Gao, et al.. (2019). A brief review: some compounds targeting YAP against malignancies. Future Oncology. 15(13). 1535–1543. 23 indexed citations
14.
Wang, Jianpeng, Dong Wang, Qingxia Ma, et al.. (2018). Circular RNA In Invasive and Recurrent Clinical Nonfunctioning Pituitary Adenomas: Expression Profiles and Bioinformatic Analysis. World Neurosurgery. 117. e371–e386. 19 indexed citations
16.
Zhao, Hongqin, Dong Wang, Zhihong Yang, et al.. (2017). FL118, a novel anticancer compound, inhibits proliferation and migration of ovarian cancer cells via up-regulation of cytoglobin in vivo and in vitro. Translational Cancer Research. 6(6). 1294–1304. 2 indexed citations
17.
Wang, Jin, Zhantao Liu, Dandan Zhang, et al.. (2017). FL118, a novel survivin inhibitor, wins the battle against drug-resistant and metastatic lung cancers through inhibition of cancer stem cell-like properties.. PubMed. 9(8). 3676–3686. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026